Inventor · disambiguated record
David Livermore
Also filed as: LIVERMORE DAVID · LIVERMORE DAVID G · LIVERMORE DAVID G H · LIVERMORE DAVID GEORGE
20 granted patents·7 pending applications·228 citations·filing 1979–2021
95Inventor score
Files withGLAXO GROUP LTD12TAKEDA PHARMACEUTICALS CO5FARNABY WILLIAM3HEPTARES THERAPEUTICS LTD2SMITHKLINE BEECHAM CORP2
Top patents by PatentIndex Score
27 records- 0197US4258041A(6R,7R)-7-[(Z)-2-(2-Aminothiazol-4-yl)-2-(2-carboxyprop-2-oxyimino)acetamido]-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate and salts thereofGLAXO GROUP LTD·Filed 1979·Granted Mar 24, 1981·106 cites·6 claims
- 0291US9593106B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2014·Granted Mar 14, 2017·20 cites·12 claims
- 0389US10030012B2Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonistsHEPTARES THERAPEUTICS LTD·Filed 2017·Granted Jul 24, 2018·9 cites·2 claims
- 0485US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0584US11129828B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0683US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 0782US4464368ACephalosporin antibioticsGLAXO GROUP LTD·Filed 1981·Granted Aug 7, 1984·14 cites·10 claims
- 0881US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 0980US9931340B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACUETICAL COMPANY LTD·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 1080US9290456B2Pyridazinone compounds and their use as DAAO inhibitorsFARNABY WILLIAM·Filed 2012·Granted Mar 22, 2016·4 cites·22 claims
- 1179US9180122B25- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and painFARNABY WILLIAM·Filed 2012·Granted Nov 10, 2015·6 cites·28 claims
- 1279US4600772ACephalosporin antibioticsGLAXO GROUP LTD·Filed 1982·Granted Jul 15, 1986·16 cites·9 claims
- 1378US12186313B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 7, 2025·0 cites·10 claims
- 1477US10463663B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 5, 2019·1 cites·16 claims
- 1568US9750748B2Pyridazinones as DAAO enzyme inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·1 cites·18 claims
- 1667US4621081ACephalosporin antibioticsGLAXO GROUP LTD·Filed 1982·Granted Nov 4, 1986·10 cites·13 claims
- 1760US4504477ACephalosporin antibioticsGLAXO GROUP LTD·Filed 1981·Granted Mar 12, 1985·4 cites·10 claims
- 1857US2013052281A1Novel compoundsFARNABY WILLIAM·Filed 2012·Application pending·0 cites
- 1955US4427675ACephalosporin antibioticsGLAXO GROUP LTD·Filed 1981·Granted Jan 24, 1984·3 cites·9 claims
- 2053US2023416202A1Small Molecule Compounds and CompositionsTELO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2148US7935832B2Pyrrole and isoindole carboxamide derivatives as P2X7 modulatorsGLAXO GROUP LTD·Filed 2008·Granted May 3, 2011·0 cites·16 claims
- 2246US2011046137A1Pyrazole Derivatives as P2X7 ModulatorsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2345US2008249092A1Novel Quinoline Compounds Capable Of Binding At The Cb2 ReceptorGIBLIN GERARD MARTIN PAUL·Filed 2006·Application pending·0 cites
- 2444US2009012056A1Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2543US2010273853A1Novel isoindol derivatives as ep4 receptor agonistsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2636US2007155805A1Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular diseaseSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 2733US10287286B2CompoundsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 14, 2019·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →